BOSTON – In the biggest criminal case ever brought in the U.S. over contaminated medicine, 14 former owners or employees of a Massachusetts pharmacy were charged Wednesday in connection with a 2012 meningitis outbreak that killed 64 people.
The nationwide outbreak was traced to tainted drug injections manufactured by the now-closed New England Compounding Center (NECC) of Framingham.
Barry Cadden, a co-founder of the business, and Glenn Adam Chin, a pharmacist who was in charge of the sterile room, were hit with the most serious charges, accused in a federal racketeering indictment of causing the deaths of 25 patients in seven states by "acting in wanton and willful disregard of the likelihood" of death or great bodily harm.
Among other things, Cadden, Chin and others are accused of using expired ingredients, failing to properly sterilize drugs and failing to test them to make sure they were pure. The other defendants, including Douglas and Carla Conigliaro, were charged with such crimes as criminal contempt, fraud and interstate sale of adulterated drugs.
U.S. Attorney Carmen Ortiz said NECC was "filthy" and failed to comply with even basic health standards, and employees falsified logs on when labs were cleaned.
"Production and profit were prioritized over safety," Ortiz said.
More than 750 people in 20 states were sickened — about half of them with a rare fungal form of meningitis, the rest with joint or spinal infections — and 64 died. The steroids given were for medical purposes, not for bodybuilding; most patients received the injections for back pain.
Roughly 1,000 Minnesotans received steroids from the contaminated lots. Twelve Minnesotans suffered fungal infections after receiving NECC's contaminated steroids at pain clinics in the Twin Cities, according to the Minnesota Department of Health. Ten consequently contracted meningitis, while two others suffered infections in their bones or bone marrow. All survived but reported a variety of lingering complications including pain, dizziness and flu-like symptoms.